Group 1 - The board of directors of Jiangsu Huifeng Bio-Agriculture Co., Ltd. held its tenth temporary meeting on August 5, 2025, with all nine directors participating [1][2]. - The meeting approved the proposal to appoint Suya Jincheng as the auditing firm for the company's 2025 financial report and internal control audit services, with a term of one year [1][2]. - The proposal received unanimous support with 9 votes in favor, and it will be submitted for review at the company's second temporary shareholders' meeting in 2025 [2]. Group 2 - The independent directors expressed their agreement with the decisions made during the board meeting, and their opinions were disclosed on the same day [2]. - The meeting's proceedings complied with the relevant laws and regulations, ensuring the independence and objectivity of the audit services [1]. - The company will publish further details regarding the appointment of the auditing firm and the upcoming shareholders' meeting on various financial news platforms [2].

Investment Rating - The investment rating for the company is "Accumulate" with a target price not specified [6] Core Viewpoints - The company is implementing an employee stock ownership plan aimed at enhancing the alignment of interests between employees and shareholders, improving corporate governance, and boosting employee morale and creativity for sustainable growth [1] - The company is actively developing its IP assets, particularly the "Little Bear Family" cartoon character, to cater to the aesthetic trends of younger consumers, resulting in significant revenue growth in related product categories, especially home textiles, which saw a 236% year-on-year increase in revenue [2] - The company possesses a unique and scarce cultural IP, "Yunjin," which has been integrated into modern product systems, creating a competitive advantage that is difficult for rivals to replicate [3] - The company maintains its profit forecast, expecting revenues of 4.6 billion, 4.9 billion, and 5.2 billion yuan for 2025-2027, with net profits of 360 million, 430 million, and 500 million yuan respectively [4] Financial Data Summary - The company’s total share capital is 346.20 million shares, with a total market capitalization of approximately 3.4 billion yuan [7] - The earnings per share (EPS) are projected to be 1.03 yuan, 1.24 yuan, and 1.44 yuan for the years 2025, 2026, and 2027 respectively [4][11] - The company’s revenue for 2023 is reported at approximately 4.54 billion yuan, with a projected growth rate of 16.55% [11][13] - The company’s gross margin is expected to remain stable, with a forecasted gross margin of 69.50% for 2025 [14]

Group 1 - The company held the first meeting of the fourth employee stock ownership plan on August 4, 2025, with 148 participants representing 1,474,781 shares, accounting for 85.74% of the total shares in the plan [1] - The meeting approved the establishment of a management committee for the employee stock ownership plan, which will consist of three members, including a chairperson [1][3] - The management committee will oversee the daily management and supervision of the employee stock ownership plan and represent the shareholders in exercising their rights [1][4] Group 2 - The management committee members elected are Chen Wanxia, Su Xiaoli, and Huang Zhuoxing, with their term aligned with the duration of the employee stock ownership plan [3] - The meeting authorized the management committee to handle various matters related to the employee stock ownership plan, including convening meetings, supervising daily management, and managing the distribution of benefits [4][5][6] Group 3 - The company provided a guarantee of up to RMB 22 million for its subsidiary, Rongke Thermal Control, to meet its operational needs, as per the maximum guarantee contract signed with Hangzhou Bank [9][12] - The total external guarantees provided by the company and its subsidiaries amount to RMB 1.624 billion, which represents 29.61% of the company's audited net assets as of December 31, 2024 [16]

证券代码：301263 证券简称：泰恩康 公告编号：2025-049 广东泰恩康医药股份有限公司 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 广东泰恩康医药股份有限公司（以下简称"公司"）第五届董事会第九次 会议（以下简称"会议"）通知于 2025 年 7 月 31 日以书面送达或电子邮件方 式向全体董事发出，会议于 2025 年 8 月 4 日在公司会议室以通讯会议的方式召 开。会议由董事长郑汉杰先生召集主持，应出席董事 7 人，实际出席董事 7 人，全部监事和高级管理人员列席会议。 本次董事会会议召集、召开符合《中华人民共和国公司法》（以下简称 "《公司法》"）《广东泰恩康医药股份有限公司章程》（以下简称《公司章 程》）等的规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议通过议案如下： （一）审议通过《关于 <广东泰恩康医药股份有限公司 ensp="ensp" 年员工持股计="年员工持股计"> 划（草案）>及其摘要的议案》 为了建立和完善劳动者与所有者的利益共享机制，进一步改善公司治理水 平，提 ...

证券代码：301263 证券简称：泰恩康 公告编号：2025-050 广东泰恩康医药股份有限公司 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 一、监事会会议召开情况 广东泰恩康医药股份有限公司（以下简称"公司"）第五届监事会第九次会 议（以下简称"会议"）通知于 2025 年 7 月 31 日以电子邮件方式向全体监事发 出，会议于 2025 年 8 月 4 日以通讯表决方式召开。会议由监事会主席林姿丽女 士召集主持，应出席监事 3 人，实际出席监事 3 人。 本次监事会会议召集、召开符合《中华人民共和国公司法》 （以下简称"《公 司法》 经与会监事充分讨论，本次会议审议通过议案如下： （一）审议《关于 <广东泰恩康医药股份有限公司 ensp="ensp" 年员工持股计划="年员工持股计划" 草 ="草"> 案）>及其摘要的议案》 为了建立和完善劳动者与所有者的利益共享机制，进一步改善公司治理水平， 提高职工的凝聚力和公司竞争力，促进公司长期、持续、健康发展，充分调动公 司员工对公司的责任意识，根据《公司法》 《中华人民共和国证券法》 《关于上市 公司实施员工 ...

证券代码：301263 证券简称：泰恩康 公告编号：2025-051 广东泰恩康医药股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》及《广东泰恩康医药股份有限公司章程》 （以 下简称"《公司章程》"）的规定，广东泰恩康医药股份有限公司（以下简称"公 司"）于 2025 年 8 月 4 日召开第五届董事会第九次会议审议通过《关于召开公司 召开 2025 年第一次临时股东大会。现将本次会议有关事项通知如下： 一、召开会议的基本情况 （1）公司第五届董事会第九次会议于 2025 年 8 月 4 日召开，审议通过《关 于召开公司 2025 年第一次临时股东大会的议案》。 （2）本次股东大会会议召集程序符合有关法律、行政法规、部门规章、规 范性文件和《公司章程》的规定。 （1）现场会议时间：2025 年 8 月 20 日（星期三）下午 15:00。 （2）网络投票时间：其中，通过深圳证券交易所（以下简称"深交所"） 交易系统进行网络投票的具体时间为：2025 年 8 月 20 日 9:15-9:25、9:30-11:30， （1 ...

Core Viewpoint - The company plans to repurchase shares through a centralized bidding method, with a total repurchase amount ranging from RMB 100 million to RMB 200 million, aimed at implementing equity incentives and/or employee stock ownership plans in the future [1][3][11]. Summary by Relevant Sections Repurchase Plan Details - The repurchase amount will not be less than RMB 100 million and not exceed RMB 200 million [1][3]. - The funding sources for the repurchase will be the company's own funds and self-raised funds, with a loan commitment of up to RMB 180 million from a bank [1][10]. - The maximum repurchase price is set at RMB 25.70 per share, which is 150% of the average trading price over the previous 30 trading days [1][9]. Repurchase Execution - The repurchase will be conducted through a centralized bidding method and is expected to be completed within 12 months from the board's approval [2][5]. - The estimated number of shares to be repurchased ranges from approximately 389,110 shares to 778,210 shares, accounting for 0.98% to 1.96% of the total share capital [7][8]. Purpose and Impact - The repurchased shares will be used for equity incentives and/or employee stock ownership plans, enhancing investor confidence and aligning the interests of shareholders and employees [5][11]. - The company believes that the repurchase will not significantly impact its operations, financial status, or future development [11][12]. Shareholder Information - As of the board's approval date, major shareholders, including directors and actual controllers, have no plans to reduce their holdings in the next three to six months [2][13]. - The company has established a dedicated securities account for the repurchase, ensuring compliance with regulations [16].

此次规模达2亿元的员工持股计划，是泰恩康对未来发展前景充满信心的有力证明，也是公司治理结构 优化的重要一步。该计划的成功实施，有望成为驱动泰恩康实现新一轮高质量发展的新引擎。 本报讯 8月4日晚间，广东泰恩康医药股份有限公司（以下简称"泰恩康"）发布公告，董事会已审议通 过《广东泰恩康医药股份有限公司2025年员工持股计划（草案）》及其摘要，并提交股东大会审议。该 计划旨在通过建立员工与股东的利益共享机制，进一步激发团队活力，提升公司治理水平，推动企业长 期可持续发展。 此次员工持股计划的参与对象范围广泛，包括公司及控股子公司的董事（不含独立董事）、监事、高级 管理人员、核心骨干员工，以及董事会认为需要纳入的其他员工（以下简称"持有人"）。初始设立时， 总参与人数不超过150人，其中董事、监事及高级管理人员7人，其他员工不超过143人。具体参与人数 及名单将根据员工实际缴款情况动态确定，公司亦可根据认购款缴纳及员工变动情况对名单及分配比例 进行调整。在存续与锁定期安排上，计划存续期为36个月，自股东大会审议通过且最后一笔标的股票购 买完成公告日起算；标的股票锁定期为12个月，锁定期满后一次性解锁。 本员工持股 ...

Core Viewpoint - The company TianKang (301263.SZ) has announced a draft employee stock ownership plan for 2025, aiming to enhance employee engagement and align interests with shareholders [1] Summary by Relevant Sections Employee Stock Ownership Plan - The employee stock ownership plan will not exceed 4.9751 million shares, representing approximately 1.17% of the company's total share capital of 425.4975 million shares as of the announcement date [1] - The plan aims to raise a maximum of 200 million yuan, with each subscription unit priced at 1.00 yuan, and the ratio of financing to self-funding will not exceed 1:1 [1] Participants and Structure - Eligible participants include directors, supervisors, senior management, core employees, and other employees deemed necessary by the board, with an initial total of no more than 150 participants [1] - The initial group consists of 7 directors (excluding independent directors) and up to 143 other employees, with the final number and list to be determined based on actual contributions [1] Duration and Lock-up Period - The plan will have a duration of 36 months, with a lock-up period of 12 months for the acquired shares, starting from the date the plan is approved by the shareholders' meeting and the last purchase of shares is completed [1] - Upon the expiration of the lock-up period, 100% of the shares will be unlocked at once [1]

泰恩康(301263.SZ)披露2025年员工持股计划(草案)，持股计划初始设立时总人数不超过150人，其中董 事(不含独立董事)、监事、高级管理人员7人，其他员工不超过143人。员工持股计划股票来源为拟通过 二级市场购买等法律法规许可的方式获得泰恩康A股，持股规模不超过497.51万股;员工持股计划拟筹集 资金总额上限为2亿元。 本员工持股计划的存续期为36个月，所获标的股票的锁定期为12个月，自本员工持股计划草案经公司股 东大会审议通过且公司公告最后一笔标的股票购买完成之日起计算。 ...